Igor Matushansky - 30 Jun 2022 Form 4 Insider Report for HOOKIPA Pharma Inc. (HOOK)

Role
Chief Medical Officer
Signature
/s/ Reinhard Kandera, as Attorney-in-Fact
Issuer symbol
HOOK
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
4
Filing time
01 Jul 2022, 16:11:01 UTC
Previous filing
20 Apr 2022
Next filing
24 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOOK Stock Option (Right to Buy) Award $0 +92,950 $0.000000 92,950 30 Jun 2022 Common Stock 92,950 $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest on April 19, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.